Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Contraceptive implants are effective, long-lasting, and safe with manageable side effects.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Calancardin B may help reduce inflammation in immune cells.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Topical imiquimod is as effective as 5-fluorouracil for treating actinic keratosis, with about a 5% risk of it turning into squamous cell carcinoma.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Delivering IGF-1 with PLGA microspheres improves stem cell regeneration for tissues.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Immunological treatment improved both neuropathy and alopecia.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Patients need better information about the risks of long-term steroid use.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

New method improves copper peptide delivery for hair growth three times better than current options.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Baricitinib is the most effective treatment for alopecia areata.